Atlas Trials

Study of ENV-294 in Adults With Moderate-to-Severe Atopic Dermatitis

Clinical trial NCT07298395 · RECRUITING

Trial details

NCT number
NCT07298395
Sponsor
Enveda Therapeutics
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Atopic Dermatitis (AD)
Start date
2025-12-22
Primary completion
2026-12-01
Enrollment
60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.